You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

363 Items

An Endorsement of the 2021 Guideline on the Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update

Document Status: In-Review
ID: GL END 3-23
Version: N/A

Oct 2021

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Nov 2024

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Mar 2025

An Endorsement of the 2025 Practical Guidelines for the Treatment of Gestational Trophoblastic Disease: Collaboration of the EOTTD, ESGO, GCIG, ISSTD

Document Status: Current
ID: GL END 4-19

Updated

Nov 2025

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Document Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Appropriate Surgical Margins and Proper Handling of Soft Tissue Sarcoma of the Extremities

Document Status: Archived
ID: 11-10

Oct 2015

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Document Status: Current

Oct 2019

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Document Status: Current

Apr 2020

Best Practice Recommendations for Regimen Development and Maintenance

Document Status: Current
ID: GL-C50-25

Feb 2016

Bevacizumab for Recurrent Glioblastoma Multiforme (GBM)

Document Status: Archived
ID: CED 19

Jul 2010

Biochemotherapy for the Treatment of Metastatic Malignant Melanoma

Document Status: Archived
ID: 8-3

Sep 2011